Wave Life Sciences Ltd. (WVE) NASDAQ

6.95

+0.275(+4.12%)

Updated at November 14 12:25PM

Currency In USD

Valuation

Market Cap1.71B
Enterprise Value1.43B
P/E Ratio-9.17
PEG Ratio-0.54
Price/Sales Ratio10.02
Price/Book Ratio8.98
Enterprise/Revenue8.4
Enterprise/EBITDA-7.09

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin-1.12
Operating Margin-1.24

Management Effectiveness

Return On Assets-4.71
Return On Equity-0.73

Income Statement

Revenue108.3M
Revenue/Share0.65
Gross Profit108.3M
EBITDA-101.74M
Net Income-97.01M
Diluted EPS-0.7

Balance Sheet

Total Cash196.22M
Total Cash/Share1.17
Total Debt19.77M
Total Debt/Equity0.16
Current Ratio2.51
Book Value Per Share0.02

Price History

52-Week Change-55.53
52-Week High16.38
52-Week Low5.28
Moving Average 50 Days7.44
Moving Average 200 Days8.06

Statistics

Average Volume2.65M
Shares Outstanding164.01M
% Held by Institutions8.98

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A